Anti-atherogenic effect of flaxseed (Linum usitatissimum) administration with a high cholesterol diet and its effect on hyperlipidemia in female Wistar rats.

Keywords: Linum usitatissimum, hyperlipidemia, CAD, arteriosclerosis


Background: Cardiovascular disease (CVD) persists to be the world's leading reason for mortality and morbidity. The major type of CVD is coronary artery disease (CAD). CAD is the obstruction of coronary arteries frequently instigated by arteriosclerosis (plaque buildup in the coronary artery, which hampers blood flow to the myocardial muscles). This research was conducted to examine the effects of oral intake of flaxseed (Linum usitatissimum) powder on hyperlipidemia and atherosclerosis (induced through high-fat diet) in female Wistar rats. The pharmacological effects of flaxseed are diverse. It has an antiarrhythmic effect, anti-arthritic effect, antilipidemic, atherosclerosis, anti‐inflammatory, antioxidant activity effect on the body. 

Methodology:  A total of 32 female Wistar rats (200 g) were divided equally into four groups. Group I (n=8) rats kept as control and given normal rat chow diet, Group II rats kept as positive control for induction of hypercholesterolemia and atherosclerosis by addition of saturated edible fat to the standard diet (high cholesterol diet - HCD), Group III rats fed with flaxseed powder at 7.5 g/kg of rat/day in the standard rat chow diet and kept as flaxseed control, and Group IV rats supplemented with flaxseed at 7.5 g/kg of rat/day along with HCD and maintained for 15 days.

Results: Group II rats showed higher lipid profile and glucose level. Flaxseed supplementation, along with a high cholesterol diet, drastically restored the serum levels of triglyceride (TG), total cholesterol (TC) decreasing frequency of CAD. Histologic investigations showed preserved myocardial walls with minor changes in flaxseed treated rats, whereas increased lymphoid aggregation with inflammation in high fat + flaxseed treated.

Conclusion:  The biochemical assays and histological results showed the moderate cardio-protective activity of flaxseed administration for 15 days along with a high-fat diet was found to moderately reduce the CVD risk in rats.


Download data is not yet available.


1. Shahid, S. U., Shabana, N. A., Rehman, A., & Humphries, S. (2018). GWAS implicated risk variants in different genes contribute additively to increase the risk of coronary artery disease (CAD) in the Pakistani subjects. Lipids in Health and Disease, 17(1), 1–7.
2. Tabei, S. M. B., Senemar, S., Saffari, B., Ahmadi, Z., & Haqparast, S. (2014). Non-modifiable Factors of Coronary Artery Stenosis in Late Onset Patients with Coronary Artery Disease in Southern Iranian Population. Journal of Cardiovascular and Thoracic Research, 6(1), 51–515.
3. Goyal, A., Patel, A., Sihag, M. K., Shah, N., & Tanwar, B. (2018). Therapeutic Potential of Flaxseed. In Therapeutic, Probiotic, and Unconventional Foods (pp. 255–274).
4. Goyal, A., Sharma, V., Upadhyay, N., Gill, S., & Sihag, M. (2014). Flax and flaxseed oil: an ancient medicine & modern functional food. Journal of Food Science and Technology, 51(9), 1633–1653.
5. 5. Heena Umer, K., Zeenat, F., Ahmad, W., Ahmad Hakim Syed Ziaul Hasan Govt, I., Vakil Khan, A., Fahmeeda Zeenat, C., & Ahmad, I. (2017). Therapeutics, phytochemistry and pharmacology of Alsi (Linum usitatissimum Linn): An important Unani drug. ~ 377 ~ Journal of Pharmacognosy and Phytochemistry, 6(5), 377–383.
6. Rodriguez-leyva, D., Bassett, C. M. C., Mccullough, R., & Pierce, G. N. (2010). Flaxseed Review Paper2. 26(9), 489–496.
7. Parikh, M., Netticadan, T., & Pierce, G. N. (2018). Flaxseed: Its bioactive components and their cardiovascular benefits. American Journal of Physiology - Heart and Circulatory Physiology, 314(2), H146–H159.
8. Prasad, K. (1999). Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation, 99(10), 1355–1362.
9. Carr, T., & Descheemaeker, K. (2008). Nutrition and Health. In Nutrition and Health.
10. Cintra, D. E. C., Costa, A. V., Peluzio, M. D. C. G., Matta, S. L. P., Silva, M. T. C., & Costa, N. M. B. (2006). Lipid profile of rats fed high-fat diets based on flaxseed, peanut, trout, or chicken skin. Nutrition, 22(2), 197–205.
11. 11. Hokanson, J. E., & Austin, M. A. (1996). Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A metaanalysis of population-based prospective studies. European Journal of Cardiovascular Prevention & Rehabilitation, 3(2), 213–219.
12. Austin, M. A., Hokanson, J. E., & Brunzell, J. D. (1994, December). Characterization of low-density lipoprotein subclasses: Methodologic approaches and clinical relevance. Current Opinion in Lipidology, Vol. 5, pp. 395–403.
13. Khanna, A. K., Rizvi, F., & Chander, R. (2002). Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. Journal of Ethnopharmacology, 82(1), 19–22.
How to Cite
Qaiser, W., Sohail, S., Khan, N. I., Naz, L., Yasmeen, G., & Shamim, M. (2020). Anti-atherogenic effect of flaxseed (Linum usitatissimum) administration with a high cholesterol diet and its effect on hyperlipidemia in female Wistar rats. International Journal of Endorsing Health Science Research (IJEHSR), 8(4), 288-294.